The Medicines Company (NASDAQ:MDCO) shares decreased -0.70% in last trading session and ended the day at $32.71. MDCO Gross Margin is 50.60% and its has a return on assets of -7.30%. The Medicines Company (NASDAQ:MDCO) quarterly performance is -21.20%.
The Medicines Company (NASDAQ:MDCO) announced its business and financial results for the fourth quarter and full year ended December 31, 2015. The net loss from continuing operations for the fourth quarter of 2015 was $68.2 million, or ($0.99) per share, compared to net income from continuing operations of $5.7 million, or $0.09 per share, for the fourth quarter of 2014.
General Motors Company (NYSE:GM) shares fell -0.82% in last trading session and ended the day at $29.03. GM Gross Margin is 12.00% and its has a return on assets of 5.20%. General Motors Company (NYSE:GM) quarterly performance is -16.59%.
On 17 February, General Motors Company (NYSE:GM) said that, it is recalling about 200,000 Saab and Saturn cars in the U.S. and Canada to replace the Takata driver’s air bag inflators.
KeyCorp. (NYSE:KEY) caters to the Financial space. It has a net profit margin of 34.10% and weekly performance is 1.14%. On the last day of trading company shares ended up at $10.64. KeyCorp. (NYSE:KEY) distance from 50-day simple moving average (SMA50) is -11.14%.
On 11 February, KeyCorp (NYSE:KEY) reiterated its commitment to upstate New York following Gov. Andrew Cuomo’s letter demanding federal officials block the bank’s acquisition of First Niagara.
Vringo, Inc. (NASDAQ:VRNG) shares increased 12.23% in last trading session and ended the day at $1.56. VRNG has a return on assets of -288.70%. Vringo, Inc. (NASDAQ:VRNG) quarterly performance is -54.12%.
On 8 February, Vringo, Inc. (NASDAQ:VRNG) announced that Bruce T. Bernstein will be joining the company’s board of directors and Ashley C. Keller will simultaneously resign.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) caters to the Healthcare space. It has a net profit margin of 48.00% and weekly performance is 14.34%. On the last day of trading company shares ended up at $27.82. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) distance from 50-day simple moving average (SMA50) is 0.67%.
On 8 February, Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) reported financial results for its fiscal first quarter ended December 31, 2015. Revenue for the three months ended December 31, 2015 was $48.4 million, compared to $77.5 million for the three months ended December 31, 2014.
Leave a Reply